Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 712363, 11 pages
http://dx.doi.org/10.1155/2015/712363
Review Article

Omega-3 Polyunsaturated Fatty Acids Intake to Regulate Helicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary Approach

CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA Bio Complex, Seongnam 463-400, Republic of Korea

Received 26 September 2014; Revised 20 December 2014; Accepted 15 January 2015

Academic Editor: Karsten Weylandt

Copyright © 2015 Jong-Min Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. E. Wroblewski, R. M. Peek Jr., and K. T. Wilson, “Helicobacter pylori and gastric cancer: factors that modulate disease risk,” Clinical Microbiology Reviews, vol. 23, no. 4, pp. 713–739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-H. Park, N. Kangwan, J.-M. Park, E.-H. Kim, and K. B. Hahm, “Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication,” World Journal of Gastroenterology, vol. 19, no. 47, pp. 8986–8995, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Conteduca, D. Sansonno, G. Lauletta, S. Russi, G. Ingravallo, and F. Dammacco, “H. pylori infection and gastric cancer: state of the art (Review),” International Journal of Oncology, vol. 42, no. 1, pp. 5–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Burlingame, C. Nishida, R. Uauy, and R. Weisell, “Fats and fatty acids in human nutrition: introduction,” Annals of Nutrition and Metabolism, vol. 55, no. 1–3, pp. 5–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Xin, W. Wei, and X. Li, “Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials,” Heart, vol. 98, no. 22, pp. 1620–1625, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kar and R. Webel, “Fish oil supplementation & coronary artery disease: does it help?” Missouri Medicine, vol. 109, no. 2, pp. 142–145, 2012. View at Google Scholar · View at Scopus
  7. E. A. Miles and P. C. Calder, “Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis,” British Journal of Nutrition, vol. 107, supplement 2, pp. S171–S184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Rudkowska, “Fish oils for cardiovascular disease: impact on diabetes,” Maturitas, vol. 67, no. 1, pp. 25–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Chapkin, W. Kim, J. R. Lupton, and D. N. McMurray, “Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 81, no. 2-3, pp. 187–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. C. Calder, “Immunomodulation by omega-3 fatty acids,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 5-6, pp. 327–335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. V. C. Vaughan, M.-R. Hassing, and P. A. Lewandowski, “Marine polyunsaturated fatty acids and cancer therapy,” British Journal of Cancer, vol. 108, no. 3, pp. 486–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Cockbain, G. J. Toogood, and M. A. Hull, “Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer,” Gut, vol. 61, no. 1, pp. 135–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Stephenson, O. Al-Taan, A. Arshad, B. Morgan, M. S. Metcalfe, and A. R. Dennison, “The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer,” Journal of Lipids, vol. 2013, Article ID 261247, 13 pages, 2013. View at Publisher · View at Google Scholar
  14. V. C. Pratt, S. Watanabe, E. Bruera et al., “Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation,” British Journal of Cancer, vol. 87, no. 12, pp. 1370–1378, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. McClinton, L. E. F. Moffat, D. F. Horrobin, and M. S. Manku, “Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer,” British Journal of Cancer, vol. 63, no. 2, pp. 314–316, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D. Z. V. Leeuwen, M. S. van der Heijden, T. Rietveld et al., “Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects,” Clinical Nutrition, vol. 21, no. 3, pp. 225–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Moore and R. A. King, “Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer,” Hormones and Cancer, vol. 3, no. 5-6, pp. 205–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Sawada, M. Inoue, M. Iwasaki et al., “Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma,” Gastroenterology, vol. 142, no. 7, pp. 1468–1475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Gu, J. Suburu, H. Chen, and Y. Q. Chen, “Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention,” BioMed Research International, vol. 2013, Article ID 824563, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Fasano, S. Serini, E. Piccioni, I. Innocenti, and G. Calviello, “Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids,” Current Medicinal Chemistry, vol. 17, no. 29, pp. 3358–3376, 2010. View at Google Scholar · View at Scopus
  21. M. Spite, “Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease,” Proceedings of the Nutrition Society, vol. 72, no. 4, pp. 441–450, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Fetterman Jr. and M. M. Zdanowicz, “Therapeutic potential of n-3 polyunsaturated fatty acids in disease,” American Journal of Health-System Pharmacy, vol. 66, no. 13, pp. 1169–1179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P. C. Calder, “n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases,” The American Journal of Clinical Nutrition, vol. 83, no. 6, supplement, pp. 1505S–1519S, 2006. View at Google Scholar
  24. P. C. Calder, “Dietary modification of inflammation with lipids,” Proceedings of the Nutrition Society, vol. 61, no. 3, pp. 345–358, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. P. Simopoulos, “Omega-3 fatty acids in inflammation and autoimmune diseases,” Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495–505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Yates, P. C. Calder, and G. Ed Rainger, “Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease,” Pharmacology and Therapeutics, vol. 141, no. 3, pp. 272–282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Kremer, “n-3 fatty acid supplements in rheumatoid arthritis,” The American Journal of Clinical Nutrition, vol. 71, no. 1, supplement, pp. 349S–351S, 2000. View at Google Scholar
  28. R. J. Goldberg and J. Katz, “A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain,” Pain, vol. 129, no. 1-2, pp. 210–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Kangwan, J. M. Park, and K. B. Hahm, “Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology,” Current Opinion in Pharmacology, vol. 19, pp. 17–23, 2014. View at Publisher · View at Google Scholar
  30. A. B. Hawthorne, T. K. Daneshmend, C. J. Hawkey a et al., “Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial,” Gut, vol. 33, no. 7, pp. 922–928, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Shimizu, T. Fujii, R. Suzuki et al., “Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis,” Journal of Pediatric Gastroenterology & Nutrition, vol. 37, no. 5, pp. 581–585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. B. G. Feagan, W. J. Sandborn, U. Mittmann et al., “Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials,” The Journal of the American Medical Association, vol. 299, no. 14, pp. 1690–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Yokoyama, T. Hamazaki, A. Ohshita et al., “Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma,” International Archives of Allergy and Immunology, vol. 123, no. 4, pp. 327–332, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Bilal, O. Haworth, L. Wu, K. H. Weylandt, B. D. Levy, and J. X. Kang, “Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses,” Biochimica et Biophysica Acta, vol. 1812, no. 9, pp. 1164–1169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Hirafuji, T. Machida, N. Hamaue, and M. Minami, “Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid,” Journal of Pharmacological Sciences, vol. 92, no. 4, pp. 308–316, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Xia, Y. Lu, J. Wang et al., “Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12499–12504, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Leaf, C. M. Albert, M. Josephson et al., “Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake,” Circulation, vol. 112, no. 18, pp. 2762–2768, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Gerbi, J.-M. Maixent, J.-L. Ansaldi et al., “Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats,” Journal of Nutrition, vol. 129, no. 1, pp. 207–213, 1999. View at Google Scholar · View at Scopus
  39. T. C. Coste, A. Gerbi, P. Vague, G. Pieroni, and D. Raccah, “Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy,” Diabetes, vol. 52, no. 10, pp. 2578–2585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. G. P. Lim, F. Calon, T. Morihara et al., “A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model,” The Journal of Neuroscience, vol. 25, no. 12, pp. 3032–3040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. C. Calder, “Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, 2014. View at Publisher · View at Google Scholar
  42. D. Schottenfeld and J. Beebe-Dimmer, “Chronic inflammation: a common and important factor in the pathogenesis of neoplasia,” CA: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 69–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Correia, V. Michel, A. A. Matos et al., “Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization,” PLoS ONE, vol. 7, no. 4, Article ID e35072, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Thompson, A. Cockayne, and R. C. Spiller, “Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration,” Gut, vol. 35, no. 11, pp. 1557–1561, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Mohammed, N. B. Janakiram, M. Brewer et al., “Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48Cre/+-LSL-KrasG12D/+ mice,” Neoplasia, vol. 14, no. 12, pp. 1249–1259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Kuriki, K. Wakai, K. Matsuo et al., “Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 11, pp. 2406–2415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Otto, U. Kaemmerer, B. Illert et al., “Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides,” BMC Cancer, vol. 8, article 122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M.-H. Wu, Y.-T. Tsai, K.-T. Hua, K.-C. Chang, M.-L. Kuo, and M.-T. Lin, “Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10,” Journal of Nutritional Biochemistry, vol. 23, no. 11, pp. 1434–1439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. Wu, J. C. Yu, Y. Q. Liu, W. M. Kang, and W. D. Guo, “Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803,” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 32, no. 1, pp. 65–70, 2010. View at Publisher · View at Google Scholar
  50. J. H. Yu, S.-G. Kang, U.-Y. Jung, C.-H. Jun, and H. Kim, “Effects of omega-3 fatty acids on apoptosis of human gastric epithelial cells exposed to silica-immobilized glucose oxidase,” Annals of the New York Academy of Sciences, vol. 1171, pp. 359–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. S. E. Lee, J. W. Lim, and H. Kim, “Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells,” Annals of the New York Academy of Sciences, vol. 1171, pp. 163–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. C. H. MacLean, S. J. Newberry, W. A. Mojica et al., “Effects of omega-3 fatty acids on cancer risk: a systematic review,” The Journal of the American Medical Association, vol. 295, no. 4, pp. 403–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Nakaya, H. Wakabayashi, L. Imamura et al., “Helicobacter pylori alters n-6 fatty acid metabolism and prostaglandin E2 synthesis in rat gastric mucosal cells,” Journal of Gastroenterology and Hepatology, vol. 16, no. 11, pp. 1197–1205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Hollander and A. Tarnawski, “Is there a role for dietary essential fatty acids in gastroduodenal mucosal protection?” Journal of Clinical Gastroenterology, vol. 13, no. 1, pp. S72–S74, 1991. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Manjari and U. N. Das, “Effect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damage,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 62, no. 2, pp. 85–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. A. E. Duggan, J. C. Atherton, A. Cockayne et al., “Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study,” British Journal of Nutrition, vol. 78, no. 4, pp. 515–522, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. S. E. Lee, J. W. Lim, J. M. Kim, and H. Kim, “Anti-inflammatory mechanism of polyunsaturated fatty acids in Helicobacter pylori-infected gastric epithelial cells,” Mediators of Inflammation, vol. 2014, Article ID 128919, 12 pages, 2014. View at Publisher · View at Google Scholar
  58. M. Correia, V. Michel, H. Osório et al., “Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid,” PLoS ONE, vol. 8, no. 4, Article ID e60657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. H. L. Woodworth, S. J. McCaskey, D. M. Duriancik et al., “Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis,” Cancer Research, vol. 70, no. 20, pp. 7960–7969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. L. M. Butler and M. C. Yu, “Fish oil exacerbates colitis in SMAD3 mice,” Cancer Research, vol. 71, no. 1, pp. 287–288, 2011. View at Google Scholar
  61. E. A. Gurzell, H. Teague, M. Harris, J. Clinthorne, S. R. Shaikh, and J. I. Fenton, “DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function,” Journal of Leukocyte Biology, vol. 93, no. 4, pp. 463–470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. S. R. Shaikh, B. D. Rockett, M. Salameh, and K. Carraway, “Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells,” The Journal of Nutrition, vol. 139, no. 9, pp. 1632–1639, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. B. D. Rockett, H. Teague, M. Harris et al., “Fish oil increases raft size and membrane order of B cells accompanied by differential effects on function,” Journal of Lipid Research, vol. 53, no. 4, pp. 674–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Meier, A. Wettstein, J. Drewe, and H. R. Geiser, “Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication,” Alimentary Pharmacology and Therapeutics, vol. 15, no. 6, pp. 851–855, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. H. A. Marsman, W. de Graaf, M. Heger et al., “Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids,” British Journal of Surgery, vol. 100, no. 5, pp. 674–683, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. H. F. Turk, J. M. Monk, Y.-Y. Fan, E. S. Callaway, B. Weeks, and R. S. Chapkin, “Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing,” American Journal of Physiology—Cell Physiology, vol. 304, no. 9, pp. C905–C917, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Gao, D. Faibish, G. Fredman et al., “Resolvin E1 and chemokine-like receptor 1 mediate bone preservation,” Journal of Immunology, vol. 190, no. 2, pp. 689–694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. J. F. Tarlton, L. J. Wilkins, M. J. Toscano, N. C. Avery, and L. Knott, “Reduced bone breakage and increased bone strength in free range laying hens fed omega-3 polyunsaturated fatty acid supplemented diets,” Bone, vol. 52, no. 2, pp. 578–586, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Bohr, S. J. Patel, D. Sarin, D. Irimia, M. L. Yarmush, and F. Berthiaume, “Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model,” Wound Repair and Regeneration, vol. 21, no. 1, pp. 35–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Zhuang, G. Wang, L. Li, G. Lin, and Z. Deng, “Omega-3 polyunsaturated fatty acids reduce vascular endothelial growth factor production and suppress endothelial wound repair,” Journal of Cardiovascular Translational Research, vol. 6, no. 2, pp. 287–293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. A. D. Widgerow, “Cellular resolution of inflammation—catabasis,” Wound Repair and Regeneration, vol. 20, no. 1, pp. 2–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. S. J. Gladman, W. Huang, S.-N. Lim et al., “Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids,” The Journal of Neuroscience, vol. 32, no. 2, pp. 563–571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. B. Ekçi, I. Karabicak, P. Atukeren, E. Altinli, K. Tomaoglu, and I. Tasci, “The effect of omega-3 fatty acid and ascorbic acid on healing of ischemic colon anastomoses,” Annali Italiani di Chirurgia, vol. 82, no. 6, pp. 475–479, 2011. View at Google Scholar · View at Scopus
  74. Y.-D. Qiu, S. Wang, Y. Yang, and X.-P. Yan, “Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats,” World Journal of Gastroenterology, vol. 18, no. 25, pp. 3288–3295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. J. W. Alexander, H. Saito, O. Trocki, and C. K. Ogle, “The importance of lipid type in the diet after burn injury,” Annals of Surgery, vol. 204, no. 1, pp. 1–8, 1986. View at Publisher · View at Google Scholar · View at Scopus
  76. M. S. Cortina, J. He, N. Li, N. G. Bazan, and H. E. P. Bazan, “Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA,” Investigative Ophthalmology and Visual Science, vol. 51, no. 2, pp. 804–810, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. O. Chow and A. Barbul, “Immunonutrition: role in wound healing and tissue regeneration,” Advances in Wound Care, vol. 3, no. 1, pp. 46–53, 2014. View at Publisher · View at Google Scholar
  78. P. Martin and S. J. Leibovich, “Inflammatory cells during wound repair: the good, the bad and the ugly,” Trends in Cell Biology, vol. 15, no. 11, pp. 599–607, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Lluís, N. Taltavull, M. Muñoz-Cortés et al., “Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats,” Lipids in Health and Disease, vol. 12, no. 1, article 140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Avramovic, V. Dragutinovic, D. Krstic et al., “The effecects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged Wistar rats,” Hippokratia, vol. 16, no. 3, pp. 241–245, 2012. View at Google Scholar · View at Scopus
  81. R. Crupi, A. Marino, and S. Cuzzocrea, “n-3 fatty acids: role in neurogenesis and neuroplasticity,” Current Medicinal Chemistry, vol. 20, no. 24, pp. 2953–2963, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. S. R. Shaikh, “Diet-induced docosahexaenoic acid non-raft domains and lymphocyte function,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4–6, pp. 159–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Calviello, S. Serini, and E. Piccioni, “n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved,” Current Medicinal Chemistry, vol. 14, no. 29, pp. 3059–3069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. B. D. Rockett, A. Franklin, M. Harris, H. Teague, A. Rockett, and S. R. Shaikh, “Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells,” Journal of Nutrition, vol. 141, no. 6, pp. 1041–1048, 2011. View at Publisher · View at Google Scholar
  85. J. Kim, Y.-N. Cha, and Y.-J. Surh, “A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders,” Mutation Research, vol. 690, no. 1-2, pp. 12–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Gao, J. Wang, K. R. Sekhar et al., “Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3,” The Journal of Biological Chemistry, vol. 282, no. 4, pp. 2529–2537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. Y.-C. Yang, C.-K. Lii, Y.-L. Wei et al., “Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-kappaB pathways,” Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 204–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Wang, T. O. Khor, C. L. L. Saw et al., “Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid,” Molecular Pharmaceutics, vol. 7, no. 6, pp. 2185–2193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Ye, L. Tan, J. Ma, Q. Shi, and J. Li, “Polyunsaturated docosahexaenoic acid suppresses oxidative stress induced endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts,” Prostaglandins Leukotrienes & Essential Fatty Acids, vol. 83, no. 1, pp. 37–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” New England Journal of Medicine, vol. 345, no. 11, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Watanabe, M. Tada, H. Nagi, S. Sasaki, and M. Nakao, “Helicobacter pylori infection induces gastric cancer in Mongolian gerbils,” Gastroenterology, vol. 115, no. 3, pp. 642–648, 1998. View at Publisher · View at Google Scholar · View at Scopus
  92. E. J. Kuipers, J. C. Thijs, and H. P. M. Festen, “The prevalence of Helicobacter pylori in peptic ulcer disease,” Alimentary Pharmacology and Therapeutics, vol. 9, supplement 2, pp. 59–69, 1995. View at Google Scholar · View at Scopus
  93. K. B. Hahm, K. J. Lee, J. H. Kim, S. W. Cho, and M. H. Chung, “Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide,” Digestive Diseases and Sciences, vol. 43, no. 9, supplement, pp. 72S–77S, 1998. View at Google Scholar · View at Scopus
  94. E. E. Mannick, L. E. Bravo, G. Zarama et al., “Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants,” Cancer Research, vol. 56, no. 14, pp. 3238–3243, 1996. View at Google Scholar · View at Scopus
  95. E. J. O'Rourke, C. Chevalier, A. V. Pinto et al., “Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2789–2794, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Bagchi, T. R. McGinn, X. Ye et al., “Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells,” Digestive Diseases and Sciences, vol. 47, no. 6, pp. 1405–1412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. S. K. Lam and N. J. Talley, “Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection,” Journal of Gastroenterology and Hepatology, vol. 13, no. 1, pp. 1–12, 1998. View at Publisher · View at Google Scholar · View at Scopus
  98. “Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. European Helicobacter pylori study group,” Gut, vol. 41, no. 1, pp. 8–13, 1997.
  99. F. Mégraud and H. Lamouliatte, “Review article: the treatment of refractory Helicobacter pylori infection,” Alimentary Pharmacology & Therapeutics, vol. 17, no. 11, pp. 1333–1343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Szabo, J. S. Trier, A. Brown, J. Schnoor, H. D. Homan, and J. C. Bradford, “A quantitative method for assessing the extent of experimental gastric erosions and ulcers,” Journal of Pharmacological Methods, vol. 13, no. 1, pp. 59–66, 1985. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Asadipour, N. Edraki, M. Nakhjiri et al., “Anti-Helicobacter pylori activity and structure-activity relationship study of 2-alkylthio-5-(nitroaryl)-1,3,4-thiadiazole derivatives,” Iranian Journal of Pharmaceutical Research, vol. 12, no. 3, pp. 281–287, 2013. View at Google Scholar · View at Scopus
  102. Y. Minami, H. Miyata, Y. Doki et al., “omega-3 Fatty acid-containing diet (Racol) reduces toxicity of chemoradiation therapy for patients with esophageal cancer,” Gan To Kagaku Ryoho, vol. 35, no. 3, pp. 437–440, 2008. View at Google Scholar · View at Scopus
  103. P. M. Kris-Etherton, “Walnuts decrease risk of cardiovascular disease: a summary of efficacy and biologic mechanisms,” Journal of Nutrition, vol. 144, no. 4, supplement, pp. 547S–554S, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. W. E. Hardman, “Diet components can suppress inflammation and reduce cancer risk,” Nutrition Research and Practice, vol. 8, no. 3, pp. 233–240, 2014. View at Publisher · View at Google Scholar
  105. W. E. Hardman, “Walnuts have potential for cancer prevention and treatment in mice,” Journal of Nutrition, vol. 144, no. 4, supplement, pp. 555S–560S, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Sezikli, Z. A. Çetinkaya, F. Güzelbulut et al., “Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation,” Helicobacter, vol. 17, no. 2, pp. 127–132, 2012. View at Publisher · View at Google Scholar · View at Scopus